Disparity in Meningococcal Vaccine Uptake Observed Among Adolescent Patients
Factors contributing to reduced uptake of MenACWY were receipt of fewer non-MenACWY vaccines, reduced preventive care visits, and visits to nonpediatric providers.
Pediatric Neurology
Alpha 2-Macroglobulin and Neuroinflammation in Acute Disseminated Encephalomyelitis
Results suggest that the ratio of the alpha 2-macroglobulin level in the cerebrospinal fluid to that in the serum reflects the neuroinflammatory status of patients with acute disseminated encephalomyelitis (ADEM) and indicates the expression of early neuroinflammation in ADEM.
Exposure to Air Pollution May Impact Children’s Cognitive Abilities
Early-life exposure to fine particulate matter (PM2.5) is associated with a reduction in fundamental cognitive abilities.
Emflaza Approved for Younger Patients With Duchenne Muscular Dystrophy
The FDA has approved an expanded indication for Emflaza (deflazacort; PTC Therapeutics, Inc.) to include children 2 to 5 years of age with Duchenne muscular dystrophy.
Relationship Between Attention and Corpus Callosum Volumes in Mucopolysaccharidosis Type I
Attention and corpus callosum volumes were found to be lower in patients with mucopolysaccharidosis type I.
Premonitory Symptoms in Children and Adolescents With Migraine
Investigators assessed the incidence of 6 frequently reported adult migraine premonitory symptoms, including fatigue and mood changes, in children and adolescents with episodic and chronic migraine.
Recommendations Developed for Pediatric Multiple Sclerosis Trials
The International Pediatric Multiple Sclerosis Study Group has updated standards for future clinical trials in pediatric multiple sclerosis.
Lyrica Approved for Partial-Onset Seizures in Patients 1 Month of Age and Older
The FDA has expanded the approval of Lyrica (pregabalin; Pfizer) for pediatric patients 1 month of age and older as adjunctive therapy for the treatment of partial-onset seizures.
Disease-Modifying Therapy Use Patterns in Pediatric Multiple Sclerosis
Investigators examine the use treatment patterns and utilization of disease-modifying therapy in newly diagnosed pediatric patients with multiple sclerosis.
Study Describes Traumatic Brain Injury Caregiver Quality of Life Measurement System
A new tool, the Traumatic Brain Injury Caregiver Quality of Life, combines five new measures and 10 existing measures and can identify health-related quality of life (HRQOL) among caregivers of individuals with TBI.
Next post in Traumatic Brain Injury
